Milestone Pharmaceuticals MIST Q1 2026 Earnings EPS Miss Deepens as ClinicalStage Biotech Navigates Development Path Oxford Lane Capital Corp 625 Series 2027 Term Preferred Shares OXLCP Q4 2025 Earnings EPS Misses Estimates by 74 as Shares Edge Higher NOAH Q3 2025 Earnings EPS of 326 Amid Market Headwinds OCC Q1 2026 Earnings Narrowed Loss and Market Sentiment Boost Drive Stock Surge Reviva Pharmaceuticals RVPH Q1 2026 Earnings EPS Beats Estimates as Cost Discipline Drives SmallerThanExpected Loss SOFI Q1 2026 Earnings EPS Slightly Below Estimates Stock Dips Marginally